V. Westeel
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
-
- Lung Cancer Treatments and Mutations 11
- Lung Cancer Diagnosis and Treatment 7
- Oncology 10
- Lung Cancer Research Studies 5
- Cancer Diagnosis and Treatment 3
- Co-authors
- B. Milleron (6 shared papers)Élisabeth Quoix (7 shared papers)Xavier Quantin (1 shared paper)Jean-Luc Breton (2 shared papers)É. Lemarié (2 shared papers)D. Del Moro (1 shared paper)Jean-Louis Pujol (1 shared paper)M. Poudenx (1 shared paper)
In The Last Decade
V. Westeel
19 papers receiving 311 citations
Peers
Comparison fields: 5 of 42
- Oncology 262
- Pulmonary and Respiratory Medicine 205
- Epidemiology 114
- Otorhinolaryngology 6
- Molecular Biology 85
Countries citing papers authored by V. Westeel
This map shows the geographic impact of V. Westeel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Westeel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Westeel more than expected).
Fields of papers citing papers by V. Westeel
This network shows the impact of papers produced by V. Westeel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Westeel. The network helps show where V. Westeel may publish in the future.
Co-authors
The 25 scholars most cited alongside V. Westeel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 111 | |
| 2 | 2010 | 71 | |
| 3 | 2010 | 46 | |
| 4 | 1998 | 42 | |
| 5 | [Respective influence of occupational and personal factors on respiratory function in dairy farmers]. | 1998 | 13 |
| 6 | 2008 | 11 | |
| 7 | 2020 | 10 | |
| 8 | 2010 | 8 | |
| 9 | [Second line chemotherapy in patients with refractory and resistant non small cell lung cancer]. | 1997 | 4 |
| 10 | [Bevacizumab and lung cancer: eligible patients in daily practice]. | 2011 | 2 |
| 11 | 2018 | 2 | |
| 12 | 2023 | 2 | |
| 13 | 2008 | 2 | |
| 14 | 2007 | 2 | |
| 15 | 2011 | 2 | |
| 16 | [Preoperative chemotherapy in non-small cell lung cancer: advantages, disadvantages, level of evidence]. | 2007 | 2 |
| 17 | 2025 | 1 | |
| 18 | 2015 | 1 | |
| 19 | [A misleading form of hypersensitivity pneumonitis]. | 2000 | 1 |
| 20 | 2011 | 1 |
About V. Westeel
V. Westeel is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 334 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Research Studies (5 papers), Cancer therapeutics and mechanisms (3 papers), Cancer Diagnosis and Treatment (3 papers), Multiple and Secondary Primary Cancers (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Oncology (262 citations), Pulmonary and Respiratory Medicine (205 citations), Epidemiology (114 citations), Otorhinolaryngology (6 citations) and Molecular Biology (85 citations). V. Westeel has collaborated with scholars based in France, China and Canada. Frequent co-authors include B. Milleron, Élisabeth Quoix, Xavier Quantin, Jean-Luc Breton, É. Lemarié, D. Del Moro, Jean-Louis Pujol, M. Poudenx, Jean Pierre Daurès and D. Debieuvre. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, JNCI Journal of the National Cancer Institute, Translational Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.